115 related articles for article (PubMed ID: 16923920)
1. Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques.
Kennedy PE; Bera TK; Wang QC; Gallo M; Wagner W; Lewis MG; Berger EA; Pastan I
J Leukoc Biol; 2006 Nov; 80(5):1175-82. PubMed ID: 16923920
[TBL] [Abstract][Full Text] [Related]
2. Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein.
Bera TK; Kennedy PE; Berger EA; Barbas CF; Pastan I
Mol Med; 1998 Jun; 4(6):384-91. PubMed ID: 10780881
[TBL] [Abstract][Full Text] [Related]
3. Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice.
Goldstein H; Pettoello-Mantovani M; Bera TK; Pastan IH; Berger EA
J Infect Dis; 2000 Mar; 181(3):921-6. PubMed ID: 10720513
[TBL] [Abstract][Full Text] [Related]
4. Continuous presence of CD4-PE40 is required for antiviral activity against single-passage HIV isolates and infected peripheral blood mononuclear cells.
Winters MA; Merigan TC
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1091-6. PubMed ID: 8312052
[TBL] [Abstract][Full Text] [Related]
5. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
Ashorn P; Englund G; Martin MA; Moss B; Berger EA
J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of recombinant Fab and Fv immunotoxins on adult T-cell leukemia lymph node and blood cells in the presence of soluble interleukin-2 receptor.
Saito T; Kreitman RJ; Hanada S; Makino T; Utsunomiya A; Sumizawa T; Arima T; Chang CN; Hudson D; Pastan I
Cancer Res; 1994 Feb; 54(4):1059-64. PubMed ID: 8313362
[TBL] [Abstract][Full Text] [Related]
8. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann T; Willingham MC; FitzGerald DJ; Pastan I
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8291-5. PubMed ID: 2236041
[TBL] [Abstract][Full Text] [Related]
9. Short communication: Activating stimuli enhance immunotoxin-mediated killing of HIV-infected macrophages.
Marsden MD; Xu J; Hamer D; Zack JA
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1399-404. PubMed ID: 19000022
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells.
Nagai T; Tanaka M; Tsuneyoshi Y; Matsushita K; Sunahara N; Matsuda T; Yoshida H; Komiya S; Onda M; Matsuyama T
Arthritis Rheum; 2006 Oct; 54(10):3126-34. PubMed ID: 17009233
[TBL] [Abstract][Full Text] [Related]
11. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TNF-alpha produced by Kupffer cells protects against the nonspecific liver toxicity of immunotoxin anti-Tac(Fv)-PE38, LMB-2.
Onda M; Willingham M; Wang QC; Kreitman RJ; Tsutsumi Y; Nagata S; Pastan I
J Immunol; 2000 Dec; 165(12):7150-6. PubMed ID: 11120846
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
Ashorn P; Moss B; Berger EA
Ann N Y Acad Sci; 1990; 616():149-54. PubMed ID: 2078015
[TBL] [Abstract][Full Text] [Related]
14. A human immunodeficiency virus-transgenic mouse model for assessing interventions that block microbial-induced proviral expression.
Schito ML; Kennedy PE; Kowal RP; Berger EA; Sher A
J Infect Dis; 2001 Jun; 183(11):1592-600. PubMed ID: 11343207
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias.
Kreitman RJ; Margulies I; Stetler-Stevenson M; Wang QC; FitzGerald DJ; Pastan I
Clin Cancer Res; 2000 Apr; 6(4):1476-87. PubMed ID: 10778980
[TBL] [Abstract][Full Text] [Related]
16. In vitro selective elimination of HIV-infected cells from peripheral blood in AIDS patients by the immunotoxin DAB389CD4.
Martín-Serrano J; Folgueira L; Laín de Lera T; Pedraza MA; Lemichez E; Sánchez-Palomino S; Noriega AR; Boquet P; Alcamí J
AIDS; 1998 May; 12(8):859-63. PubMed ID: 9631138
[TBL] [Abstract][Full Text] [Related]
17. Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
Pincus SH; Song K; Maresh GA; Frank A; Worthylake D; Chung HK; Polacino P; Hamer DH; Coyne CP; Rosenblum MG; Marks JW; Chen G; Weiss D; Ghetie V; Vitetta ES; Robinson JE; Hu SL
J Virol; 2017 Feb; 91(3):. PubMed ID: 27795412
[TBL] [Abstract][Full Text] [Related]
18. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
19. A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types.
Lueders KK; De Rosa SC; Valentin A; Pavlakis GN; Roederer M; Hamer DH
AIDS Res Hum Retroviruses; 2004 Feb; 20(2):145-50. PubMed ID: 15018701
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]